A Firsthand Account Of The Helsinn V. Teva Arguments
Law360 (December 7, 2018, 12:22 PM EST) -- On Dec. 4, 2018, the U.S. Supreme Court heard oral arguments in Helsinn Healthcare v. Teva Pharmaceuticals. The question before the court was whether the America Invents Act of 2011 altered the "on-sale bar" such that sales and offers for sale that do not make the claimed invention "available to the public" no longer qualify as invalidating prior art. The oral arguments, which the authors of this article attended, were spirited and filled with laughter-inducing but challenging hypotheticals.
But while the oral arguments highlighted the stark differences between and exposed key weaknesses in each party's position, they did not provide much...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!